Stock fact sheet · data as of
CompuMed, Inc. (CMPD): fair value, margin of safety and Wheel Score
Healthcare · Medical - Healthcare Information Services · United States · Speculative / Distressed
Is CMPD undervalued?
CMPD closed at 6.30 on 16 Oct 2026, 12% below the GLS average fair value of 7.16 from 2 models (1 of them above the price). That is a moderate margin of safety: the stock passes the "below fair value" rule of the Sunday Scan, and the Wheel Score gives it 18 of the 25 Value points.
Only 2 of the nine models produced a value (DCF, 10 Cap); the others need a dividend, positive free cash flow or positive book value the company does not have yet, so the average rests on a narrow base.
The nightly engine files CMPD under Speculative / Distressed - negative earnings or a Piotroski score of 3 or less - which caps its Wheel Score at 45 and keeps it out of the Sunday Scan.
Nine valuation models for CMPD
Each model turns the latest filed numbers into a value per share; the GLS fair value is the simple average of the ones that produce a positive number. The last two rows are shown for reference and never enter the average. The Quote page lets you switch any model off and add your own margin of safety.
| Model | Value | vs price | What it measures |
|---|---|---|---|
| DCF | 5.79 | -8% | Present value of the projected free cash flows, discounted at the cost of capital |
| Graham Number | - | - | The most a defensive investor pays for the earnings and book value per share; no value tonight |
| Graham Growth | - | - | Graham's growth formula: EPS × (8.5 + 2 × growth), adjusted for bond yields; no value tonight |
| Lynch | - | - | EPS × the earnings growth rate (PEG of 1), growth capped at 25%; no value tonight |
| GLS Growth | - | - | EPS compounded ten years at the blended growth rate, discounted back at 15% a year; no value tonight |
| 10 Cap | 8.54 | +36% | Owner's earnings (operating cash flow less maintenance capex) capitalised at 10% |
| Payback Time | - | - | Eight years of compounded free cash flow: the price at which the business pays for itself; no value tonight |
| DDM | - | - | Dividend discount model: next year's dividend ÷ (10% − 3% growth); needs a dividend; no value tonight |
| EPV | - | - | Earnings power value: current EPS capitalised at 9% with no growth; no value tonight |
| Zombie (liquidation) | 0.7731 | -88% | Current assets less all liabilities, per share: the balance-sheet floor. Not in the average |
| Wall St target | 0.0000 | -100% | Analysts' average 12-month price target. Not in the average |
Quality and financial health
Financial health is average - CMPD passes 5 of the nine Piotroski tests, which falls one point short of the Sunday Scan's "6 or more" rule. The Financials tab on the Quote page shows which tests fail. The GLS Moat score is low at 3.2 out of 10, which says the ten-year record of revenue, earnings, margins and returns on capital has been inconsistent - growth and shocks rather than steady compounding.
Returns on capital are thin or negative - ROIC -1.7%, ROE -2.1%, ROA -1.3% - with debt at 0.23 times equity and a free-cash-flow yield of 6.4%.
CompuMed, Inc. pays no dividend, so the DDM model does not apply and a covered-call holder earns only the premium and any price gain.
Institutional ownership scores 5/10, insider activity 5/10 and Congressional trading 5/10 on the GLS smart-money scales.
| Piotroski F-score | 5 / 9 | ROIC | -1.7% |
|---|---|---|---|
| GLS Moat | 3.2 / 10 | ROE | -2.1% |
| Debt / equity | 0.23 | ROA | -1.3% |
| Free-cash-flow yield | 6.4% | Payout ratio | 0% |
| Institutions | 5 / 10 | Insiders · Congress | 5 · 5 / 10 |
Wheel Score 39: No options
CMPD has no listed options in the nightly snapshot, so there is nothing to sell and the stock cannot be wheeled however good the business; the Wheel Score is capped at 39 and shown as "No options" (39 here). The valuation and quality numbers still apply to owning the shares outright.
Volume runs at 0k shares a day on a market cap of $8M, with a beta of -0.58 - a low beta, so day-to-day moves are smaller than the market's; the Stability part of the Wheel Score gives that 6 of 20.
| Part | Points | From | |
|---|---|---|---|
| Value | 18 / 25 | 12% margin of safety | |
| Health | 11 / 20 | Piotroski 5/9 | |
| Moat | 5 / 15 | moat 3.2/10 | |
| Premium | 0 / 20 | no option data | |
| Stability | 6 / 20 | 0k shares/day, $8M cap, beta -0.58 |
The Wheel Score ranks ~7,400 US stocks for selling cash-secured puts and covered calls; it is updated nightly and is not a recommendation. The walkthrough lesson shows how the score fits into a trade, start to finish.
Upcoming events
No upcoming earnings date is recorded for CMPD in the nightly calendar.
Earnings, dividend, IPO, split and economic calendars for the whole market, filterable to your watchlists.
Similar stocks in Medical - Healthcare Information Services
The 12 companies below are the closest to CompuMed, Inc. by market cap within the Medical - Healthcare Information Services industry, each with its own fact sheet; the Compare page puts up to eight of them side by side.
| Stock | Close | Fair value | MoS | Wheel | Mkt cap |
|---|---|---|---|---|---|
| VYND Vynleads, Inc. | 0.4098 | - | - | 19No options | $8M |
| MGRX Mangoceuticals, Inc. | 0.3210 | 0.0685 | -368% | 18No options | $7M |
| BFRG Bullfrog AI Holdings, Inc. Common Stock | 0.5348 | 0.2125 | -152% | 21No options | $10M |
| HCTI Healthcare Triangle, Inc. | 0.4173 | - | - | 27No options | $6M |
| ACON Aclarion, Inc. | 1.95 | 20.69 | +91% | 38No options | $6M |
| EBYH Strainsforpains, Inc. | 0.2480 | - | - | 24No options | $3M |
| ONMD OneMedNet Corporation | 4.75 | - | - | 25No options | $28M |
| WORX SCWorx Corp. | 2.14 | 2.59 | +17% | 39No options | $34M |
| VRHI Veri Medtech Holdings Inc. | 4.41 | 0.5753 | -667% | 20No options | $35M |
| WLSS Welsis Corp. | 0.6000 | - | - | 23No options | $2M |
| VASO Vaso Corporation | 0.2900 | 0.3935 | +26% | 39No options | $51M |
| CCLD CareCloud, Inc. | 1.93 | 4.23 | +54% | 53Fair | $82M |
Screen the whole market the same way
A free GLS Equity account gets you nightly fair value and the Wheel Score on ~7,400 US stocks, a watchlist, the scanner preview and the Sunday Scan - the same eight-rule screen, emailed every week. Pro adds the full put and call scanners, unlimited watchlists with alerts and the trade journal.
Start free See the Sunday ScanQuestions about CMPD
Is CMPD undervalued right now?
By the GLS models, moderately: at 6.30 the stock trades 12% below the average fair value of 7.16 (data as of 16 Oct 2026).
What is the Wheel Score of CMPD and what does it mean?
CMPD has no listed options in our nightly snapshot, so it cannot be wheeled; its Wheel Score is capped at 39 and shown as "No options".
What is the GLS fair value for CMPD?
7.16 per share as of 16 Oct 2026 - the simple average of the 2 valuation models (out of nine: DCF, Graham Number, Graham Growth, Lynch, GLS Growth, 10 Cap, Payback Time, DDM and EPV) that produced a positive value. The models run every night on the latest filings; the Quote page lets you switch any of them off and add a margin of safety of your own.
When does CompuMed, Inc. report earnings next?
No upcoming earnings date is recorded for CMPD in our calendar as of 16 Oct 2026; the Calendars page is refreshed every morning.
Does CMPD have listed options, and how liquid are they?
No. The nightly options snapshot found no listed contracts on CMPD, so the wheel strategy cannot be run on it and the Wheel Score is capped at 39.